INTERNATIONAL PATENT: SANOFI FILES APPLICATION FOR "TREATMENT OF HIGH-RISK ASTHMA BY BLOCKING IL-13 AND TSLP"

GENEVA, March 2 -- SANOFI (46 avenue de la Grande Armee75017 Paris) filed a patent application (PCT/EP2025/073887) for "TREATMENT OF HIGH-RISK ASTHMA BY BLOCKING IL-13 AND TSLP" on Aug 21, 2025. With publication no. WO/2026/041740, the details related to the patent application was published on Feb 26, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HARDIN, Megan (c/o SanofiPatent Department450 Water StreetCambridge, MA 02141), MALEY, Jason H. (c/o SanofiPatent Department450 Water StreetCambridge, MA 02141), STAUDINGER, Heribert (c/o SanofiPatent Department450 Water StreetCambridge, MA, 02141...